Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25–35 model of Alzheimer's disease

@article{Galoyan2008NeuroprotectionBH,
  title={Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25–35 model of Alzheimer's disease},
  author={A. Galoyan and J. S. Sarkissian and V. A. Chavushyan and I. Meliksetyan and D. Abrahamyan},
  journal={Alzheimer's & Dementia},
  year={2008},
  volume={4},
  pages={332-344}
}
  • A. Galoyan, J. S. Sarkissian, +2 authors D. Abrahamyan
  • Published 2008
  • Medicine
  • Alzheimer's & Dementia
  • This work sought to determine the effects of hypothalamic proline‐rich peptide (PRP)‐1 in a rat model of Alzheimer's disease. 
    22 Citations
    The role of monoamines in the development of Alzheimer's disease and neuroprotective effect of a proline rich polypeptide
    • 5
    Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice
    • Juan Zou, Pei-shan Cai, Chao-mei Xiong, J. Ruan
    • Chemistry, Medicine
    • Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
    • 2016
    • 9
    Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer’s Disease Model Rats by Maintaining Synaptic Plasticity
    • 13
    Selenoprotein P and selenoprotein M block Zn2+ -mediated Aβ42 aggregation and toxicity.
    • 32
    • PDF

    References

    SHOWING 1-10 OF 61 REFERENCES
    Preclinical Evidence of Neuroprotection by Cholinesterase Inhibitors
    • A. Akaike
    • Psychology, Medicine
    • Alzheimer disease and associated disorders
    • 2006
    • 49
    Mitochondrial dysfunction and Alzheimer's disease: new developments.
    • 25